Patient Preference and Adherence (Aug 2013)
User assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective study [Corrigendum]
Abstract
Tauber M, Jaquet D, Jesuran-Perelroizen M, Petrus M, Bertrand AM, Coutant R. Patient Preference and Adherence. 2013;7:455–462.On pages 455; 456; 458 and 459 NordiFlex manufacturer’s details were incorrectly listed as "Novo Nordisk, Princeton, NY, USA". The correct manufacturer’s details are "Novo Nordisk A/S, Bagsværd, Denmark".Read the original article